New Study Links Paxil to Twice as Many Birth Defects as Other Antidepressants
The FDA and the drug company GlaxoSmithKline are alerting doctors about a new study on major birth defects seen in babies born to women who took the antidepressant Paxil during the first trimester of pregnancy.